Merck nears US$10 billion deal for London-based lung therapy firm Verona, FT reports
July 9, 2025
[ad_1] [LONDON] Merck is nearing a US$10 billion deal to buy lung diseases focussed Verona Pharma, as the US drugmaker is eyeing deals to offset the upcoming patent expiry of...
